REFERENCES
- Harada N, Utsumi T, Takagi Y. Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc Natl Acad Sci USA 1993; 90(23)11312–11316, [PUBMED], [INFOTRIEVE], [CSA]
- Agarwal VR, Bulun SE, Leitch M, Rohrich R, Simpson ER. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J Clin Endocrinol Metab 1996; 81(11)3843–3849, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Utsumi T, Harada N, Maruta M, Takagi Y. Presence of alternatively spliced transcripts of aromatase gene in human breast cancer. J Clin Endocrinol Metab 1996; 81(6)2344–2349, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sebastian S, Takayama K, Shozu M, Bulun SE. Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue. Mol Endocrinol 2002; 16(10)2243–2254, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Richards JA, Petrel TA, Brueggemeier RW. Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells. J Steroid Biochem Mol Biol 2002; 80(2)203–212, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Brodie AM, Lu Q, Long BJ, Fulton A, Chen T, Macpherson N, DeJong PC, Blankenstein MA, Nortier JW, Slee PH, van de Ven J, van Gorp JM, Elbers JR, Schipper ME, Blijham GH, Thijssen JH. Aromatase and COX-2 expression in human breast cancers. J Steroid Biochem Mol Biol 2001; 79(1–5)41–47, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Egawa C, Miyoshi Y, Iwao K, Shiba E, Noguchi S. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in normal and malignant thyroid tissues by real-time polymerase chain reaction. Oncology 2001; 61(4)293–298, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Girault I, Lerebours F, Tozlu S, Spyratos F, Tubiana-Hulin M, Lidereau R, Biech I. Real-time reverse transcription PCR assay of CYP19 expression: application to a well-defined series of post-menopausal breast carcinomas. J Steroid Biochem Mol Biol 2002; 82(4–5)323–332, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Miyoshi Y, Taguchi T, Gustafsson JA, Noguchi S. Clinicopathological characteristics of estrogen receptor-beta-positive human breast cancers. Jpn J Cancer Res 2001; 92(10)1057–1061, [PUBMED], [INFOTRIEVE], [CSA]
- Harada N. Novel properties of human placental aromatase as cytochrome P-450: purification and characterization of a unique form of aromatase. J Biochem (Tokyo) 1988; 103(1)106–113, [CSA]
- Singh-Ranger G, Kirkpatrick KL, Clark GM, Mokbel K. Cyclo-oxygenase-2 (COX-2) mRNA expression correlates with progesterone receptor positivity in human breast cancer. Curr Med Res Opin 2003; 19(2)131–134, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Davies G, Martin LA, Sacks N, Dowsett M. Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention. Aromatase and COX-2 expression in human breast cancers. Ann Oncol 2002; 13(5)669–678, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]